New research suggests vitamin B1 could become a novel adjunct therapy for certain cancers

Read more

Materials Used: Biocompatible Polymers: Materials like PEEK and specialized hydrogels that integrate seamlessly with human tissues. Cellular Scaffolds: For organs like skin, stem cells from the patient’s own body are used to grow bioengineered tissue. Precision Engineering: 3D scans of the damaged organ are captured with 0.1mm accuracy for custom design. Layer-by-layer printing using advanced bioprinters. 2. Leading Hospitals in China West China Hospital (Chengdu): Performed the world’s first 3D-printed artificial kidney transplant in 2022. Printed organs …

Read more

The latest advancements in CAR-T cell therapy presented at ESMO 2024 underscore the rapid evolution of this treatment modality. Novel engineering approaches are addressing major challenges in both hematologic and solid tumors, offering promising solutions for long-term efficacy, tumor penetration, and safety. As these therapies move towards commercialization, they hold immense potential to redefine cancer treatment paradigms.

Read more

Glioblastoma (Glioblastoma Multiforme - GBM) is one of the most aggressive forms of brain cancer, characterized by rapid growth and high resistance to existing treatments. This malignancy primarily affects adults and presents symptoms such as headaches, seizures, and cognitive impairments. Due to the complexity of treating glioblastoma, researchers and pharmaceutical companies worldwide are developing a comprehensive roadmap of innovative therapies to improve patient survival and quality of life.

Read more

Utilizing bispecific antibodies (BsAbs) to enhance T-cell engagement in solid tumors is a breakthrough strategy in cancer immunotherapy, offering new hope for treating solid tumors that are often resistant to conventional therapies. Bispecific antibodies are engineered to simultaneously bind to tumor-associated antigens (TAAs) on cancer cells and T-cell surface markers such as CD3. This dual targeting creates a bridge between T cells and tumor cells, enhancing T-cell activation and tumor …

Read more

In recent years, cancer treatment has witnessed significant breakthroughs that not only improve survival rates but also pave the way for more targeted and personalized therapies. Among these advancements, artificial intelligence (AI), cell therapy, and immunotherapy are at the forefront. This article explores the latest trends in cancer treatment for 2025, focusing on AI-driven predictions, cell-based therapies, and the impact of climate change and social disparities on cancer treatment and outcomes.

Read more

Brain and spinal cord cancers, particularly Diffuse Midline Gliomas (DMGs), are among the most aggressive and fatal types of cancers, especially in children and young adults. These cancers, including the H3K27M-mutant variant, typically progress rapidly and are usually fatal within a year of diagnosis. Standard treatments, such as chemotherapy and radiation, offer only temporary relief and fail to significantly alter the disease’s course. In recent years, CAR T-Cell therapy, an innovative form of immunothera.

Read more

China has become a leading global destination for medical tourism, attracting patients from all corners of the world. With world-class healthcare facilities, state-of-the-art technologies, and highly skilled medical professionals, China offers an array of medical treatments ranging from cancer therapies to advanced cosmetic surgery. In this guide, we’ll explore the top medical tourism destinations in China, detailing their specialized treatments, renowned hospitals, and essential tips for international patients.

Read more

In recent years, China has emerged as a global hub for the biotechnology and pharmaceutical industry. With massive investments in research and development, government support, and the presence of innovative companies, China has made significant strides in areas such as cancer immunotherapy, biologics, and personalized medicine. In this article, we explore the top 10 biotech and pharmaceutical companies in China and their role in transforming the healthcare industry.

Read more

While CAR-T cell therapies have shown remarkable success in blood cancers, their effectiveness in solid tumors has remained a significant challenge. CAR-T therapies, specifically designed for blood cancers, face considerable hurdles in solid tumors due to the complex tumor microenvironment. However, recent research has introduced the TBK1 gene as a potential new therapeutic target that can enhance CAR-T efficacy in solid tumors.

Read more